EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study

Shantelle Claassen-Weitz iD, Yao Xia, Luke Hannan, Sugnet Gardner-Lubbe iD, Kilaza S Mwaikono iD, Stephanie Harris Mounaud, William C Nierman iD, Lesley Workman iD, Felix S Dube, Samantha Africa iD, Fadheela Patel iD, Veronica Allen und 3 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf184 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Shantelle Claassen-Weitz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Nasopharynx, Respiratory Tract Infections, Microbiota. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Australian National Health and Medical Research Council, Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lower respiratory tract infections (LRTIs) in infants are caused by viral and bacterial infections. We investigated associations between LRTI and nasopharyngeal (NP) viruses and bacteria in South African infants.

Methods

In a birth cohort, LRTI cases were identified prospectively and age-matched with controls. NP swabs were tested using polymerase chain reaction and 16S RNA gene sequencing. We calculated adjusted conditional odds ratios (aORs) and used mixed-effects models to identify differentially abundant taxa and explore viral–bacterial interactions.

Results

A total of 888 case-control samples were tested. Respiratory syncytial virus (RSV) (aOR, 5.69 [95% confidence interval, 3.03–10.69]), human rhinovirus (HRV) (1.47 [1.03–2.09]), parainfluenza virus (3.46 [1.64–7.26]), adenovirus (1.99 [1.08–3.68]), enterovirus (2.32 [1.20–4.46]), Haemophilus influenzae (1.72 [1.25–2.37]), Klebsiella pneumoniae (2.66 [1.59–4.46]), and high-density Streptococcus pneumoniae (1.53 [1.01–2.32]) were associated with LRTI. LRTI was associated with decreased relative abundance of Dolosigranulum (q = .001), Corynebacterium (q = .091), and Neisseria (q = .004). In samples positive for RSV, Staphylococcus and Alloprevotella relative abundance was higher in controls compared to cases. In samples positive for parainfluenza virus or HRV, Haemophilus relative abundance was higher in cases. Detection of cytomegalovirus (CMV) in controls was associated with reduced Corynebacterium, Dolosigranulum, and Staphylococcus.

Conclusions

The associations between bacteria, viruses and LRTIs are similar to those from high-income countries. Haemophilus is a major bacterial driver of LRTIs, acting synergistically with viruses. Dolosigranulum and Corynebacterium may reduce LRTI risk, while Staphylococcus may reduce the risk of RSV-related LRTIs. CMV is associated with dysbiotic nasopharyngeal microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NasopharynxRespiratory Tract InfectionsMicrobiotaHumansSouth AfricaCase-Control StudiesInfantMaleFemaleProspective StudiesVirusesBacteriaRNA, Ribosomal, 16SInfant, NewbornVirus Diseases

Stichwörter der Autor:innen

16S rRNA geneinfantlower respiratory tract infectionmicrobiotaviral

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Marshall Centre, Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia.
  • Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Stellenbosch, South Africa.
  • Department of Statistics and Actuarial Science, Faculty of Economic and Management Sciences, Stellenbosch University, Stellenbosch, South Africa.
  • Computational Biology Group and H3ABioNet, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.
  • Department of Science and Laboratory Technology, Dar es Salaam Institute of Technology, Dar es Salaam, Tanzania.

ORCID-Profile: Shantelle Claassen-Weitz, Sugnet Gardner-Lubbe, Kilaza S Mwaikono, William C Nierman, Lesley Workman, Samantha Africa, Fadheela Patel, Mark P Nicol

Förderung

  • NIH HHS
  • Australian National Health and Medical Research Council
  • Gates Foundation
  • National Research Foundation of South Africa
  • Investigator Grant
  • South African Medical Research Council
  • L'Oréal-UNESCO For Women in Science
  • Drakenstein Child Health Study

Zitieren

APA

Claassen-Weitz, S., Xia, Y., Hannan, L., Gardner-Lubbe, S., Mwaikono, K. S., Harris Mounaud, S., Nierman, W. C., Workman, L., Dube, F. S., Africa, S., Patel, F., Allen, V., Ah Tow Edries, L., Zar, H. J., & Nicol, M. P. (2026). Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf184

Vancouver

Claassen-Weitz S, Xia Y, Hannan L, Gardner-Lubbe S, Mwaikono KS, Harris Mounaud S, et al. Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf184

BibTeX
@article{ClaassenWeitz2026,
  author = {Claassen-Weitz, Shantelle and Xia, Yao and Hannan, Luke and Gardner-Lubbe, Sugnet and Mwaikono, Kilaza S and Harris Mounaud, Stephanie and Nierman, William C and Workman, Lesley and Dube, Felix S and Africa, Samantha and Patel, Fadheela and Allen, Veronica and Ah Tow Edries, Lemese and Zar, Heather J and Nicol, Mark P},
  title = {Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf184}
}
Kostenlos starten →